Pfizer Says Strong Response From 3 Covid Shots in Young Children
Pfizer and BioNTech said on Monday that preliminary findings of a clinical trial of children younger than five showed three doses of their coronavirus vaccine produced a strong enough immune response to meet the criteria for regulatory authorization. In a news release, the companies announced results from a subset of a trial of 1,678 children…
Details